Cushing’s Syndrome: All Variants, Detection, and Treatment
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Synopsis Cushing’s syndrome is caused by prolonged exposure to excess glucocorticoids. Diagnosis of Cushing’s syndrome involves a step-wise approach and establishing the cause can be challenging in some cases. Hypertension is present in about 80% of patients with Cushing’s syndrome and can lead to significant morbidity and mortality. Several pathogenic mechanisms have been proposed for glucocorticoid-induced hypertension including a functional mineralocorticoid excess state, up-regulation of the renin angiotensin system and deleterious effects of cortisol on the vasculature. Surgical excision of the cause of excess glucocorticoids remains the optimal treatment for Cushing’s syndrome. Anti-glucocorticoid and antihypertensive agents and steroidogenesis inhibitors can be used as adjunctive treatment modalities in preparation for surgery, and in cases where surgery is contraindicated or has not led to cure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 1×
“guidelines, any of the following tests can be used for the initial diagnosis of Cushing’s syndrome: 24-hour urinary free cortisol, late-night salivary cortisol, or a dexamethasone suppression test (DST, either as a 1-mg overnight test or the longer low-dose test using 2 mg/d over 48 hours).(9)”
MethodSelf-citationMineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628 · cited 1×
“The in vivo selectivity of the renal mineralocorticoid receptor for aldosterone requires conversion of cortisol to cortisone by 11bHSD2, rendering it unable to bind to the mineralocorticoid receptor.(28,29) The global activity of 11bHSD can be assessed by measurement of urinary steroid”
BackgroundMorbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.
Magiakou, M. A., Mastorakos, G., Oldfield, E. H., Gomez, M. T., Doppman, J. L., Cutler, G. B., Nieman, L. K., & Chrousos, G. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311002 · Cited by 430 · cited 1×
“The clinical presentation differs in children, in whom weight gain and growth retardation are more prominent.(8) Biochemical confirmation of hypercortisolism is necessary when the clinical presentation suggests Cushing’s syndrome.”
BackgroundSelf-citationROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390 · cited 1×
“However, some of the signs that have been reported to better distinguish Cushing’s syndrome from simple obesity include proximal muscle weakness, easy bruising, violaceous striae greater than 1 cm, and hypertension.(6,7) The clinical presentation differs in children, in whom weight gain and growth retardation are more…”
BackgroundFaggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021558 · Cited by 358 · cited 1×
“In one prospective study, ultrasound identified atherosclerotic plaques in both carotid arteries in 8 of 25 subjects with active Cushing’s disease and 2 of 32 age-, sex-, and body mass index-matched controls.(13) Hypertension, impaired glucose tolerance, diabetes, dyslipidemia, and visceral obesity are common cardiova…”
BackgroundOccult Cushing’s syndrome in type-2 diabetes
Catargi, B., Rigalleau, V., Poussin, A., Ronci-Chaix, N., Bex, V., Vergnot, V., Gin, H., Roger, P., & Tabarin, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030254 · Cited by 287 · cited 1×
“More recent data suggests that this is probably an underestimate and Cushing’s syndrome may be more common than previously thought.(4,5) Iatrogenic Cushing’s syndrome caused by the administration of supraphysiologic doses of glucocorticoids is probably much more common (although underreported) than endogenous causes.”
BackgroundHypertension and the cortisol-cortisone shuttle
Quinkler, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030138 · Cited by 286 · cited 4×
“These findings are similar to those in patients with inactivating mutations of 11bHSD2 who have a syndrome of apparent mineralocorticoid excess (SAME).(25) However, in SAME, the aldosterone and renin levels are suppressed in comparison to those seen in Cushing’s syndrome.”
BackgroundResultInfluentialLeibowitz, G., Tsur, A., Chayen, S. D., Salameh, M., Raz, I., Cerasi, E., & Gross, D. J. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.737558.x · Cited by 180 · cited 1×
“More recent data suggests that this is probably an underestimate and Cushing’s syndrome may be more common than previously thought.(4,5) Iatrogenic Cushing’s syndrome caused by the administration of supraphysiologic doses of glucocorticoids is probably much more common (although underreported) than endogenous causes.”
BackgroundProbability theory in the diagnosis of Cushing's syndrome.
NUGENT, C. A., WARNER, H. R., DUNN, J. T., & TYLER, F. H. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-7-621 · Cited by 112 · cited 1×
“However, some of the signs that have been reported to better distinguish Cushing’s syndrome from simple obesity include proximal muscle weakness, easy bruising, violaceous striae greater than 1 cm, and hypertension.(6,7) The clinical presentation differs in children, in whom weight gain and growth retardation are more…”
Background
Cited by
Cushing's syndrome: epidemiology and developments in disease management
Feelders, R., Sharma, S., & Nieman, L. (2015) · Clinical Epidemiology · doi:10.2147/clep.s44336 · Cited by 210
“Hypertension (cortisolmediated enhancement of vascular reactivity to vasoconstrictors and the mineralocorticoid effects of cortisol), though not invariably present, is frequently seen in patients with Cushing’s syndrome, with a prevalence of approximately 80%.(35,55) Hepatic steatosis and increased visceral adipose ti…”
Self-citationNeural Regulation of the Stress Response: The Many Faces of Feedback
Myers, B., McKlveen, J. M., & Herman, J. P. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9801-y · Cited by 175
“The vast majority of these patients exhibit obesity, hypertension, impaired glucose tolerance, diabetes, and dyslipidemia (Sharma and Nieman 2011).”
Raff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141
“…intolerance, hypertension (related to upregulation of the renin-angiotensin system and the mineralocorticoid effects of cortisol described earlier) (232) and a hypercoagulable state [related to increased synthesis of clotting factors like fibrinogen as well as plasminogen activator inhibitor…”
Self-citationFleseriu, M., & Castinetti, F. (2016) · Pituitary · doi:10.1007/s11102-016-0742-1 · Cited by 87
Brue, T., Amodru, V., & Castinetti, F. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1058 · Cited by 85
Metadata
- Authors
- Sharma, S. T., & Nieman, L. K.
- Venue
- Endocrinology and Metabolism Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 40
- Issue
- 2
- Pages
- 379-391
- ISSN
- 0889-8529 (ISSN-L)
- OpenAlex
- W2024546597
- Cited by
- 89
- References
- 10
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cushing’s Syndrome: All Variants, Detection, and Treatment. https://app.cochat.ai/papers/10.1016/j.ecl.2011.01.006
- The paper
- Sharma, S. T., & Nieman, L. K. (2011). Cushing’s Syndrome: All Variants, Detection, and Treatment. Endocrinology and Metabolism Clinics of North America. https://doi.org/10.1016/j.ecl.2011.01.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.